Breaking News

Tweet TWEET

Solazyme to Showcase Breakthrough Microalgae Food Ingredients at IFT

  Solazyme to Showcase Breakthrough Microalgae Food Ingredients at IFT

Business Wire

SOUTH SAN FRANCISCO, Calif. -- July 11, 2013

Solazyme, Inc. (SZYM), a renewable oil and bioproducts company announced today
that they will be exhibiting at the Institute of Food Technologists (IFT) 2013
Annual Meeting and Expo. Solazyme’s innovative microalgae food ingredients
include a suite of revolutionary high lipid and high protein products as well
as a tailored food oils portfolio. Products in the portfolio provide health
benefits without sacrificing taste, texture, or functionality. Solazyme will
be exhibiting and sampling prototype products that will include these
ingredients at IFT.

“Solazyme’s unique microalgae platform provides significant opportunities for
the food industry to dramatically improve the health profile of their products
without sacrificing the qualities that consumers demand,” said Jean-Marc
Rotsaert, Chief Operating Officer, Solazyme. “For the first time in history, a
suite of products is now available that can have a positive impact on obesity
and weight control, provide shorter and cleaner ingredient labels, and reduce
food allergens, all while using sustainable and naturally derived
ingredients.”

GRAS certifications for certain microalgae food ingredients can be located
under U.S. Food and Drug Administration GRAS Inventory Number GRN 000469 and
GRN 000331.

To learn more about Solazyme’s innovative suite of microalgae ingredients,
please visit the sales team at IFT booth #2991 or visit us at
www.solazyme.com.

About Solazyme, Inc.

Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils and
innovative microalgal food ingredients. Headquartered in South San Francisco,
Solazyme’s renewable products can replace or enhance oils derived from the
world's three existing sources — petroleum, plants and animal fats. Initially,
Solazyme is focused on commercializing its products into three target markets:
(1) fuels and chemicals, (2) nutrition and (3) skin and personal care.

Solazyme®, the Solazyme logo and other trademarks or service names are
trademarks of Solazyme, Inc.

Forward Looking Statements

This press release contains certain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 about
Solazyme, including statements that involve risks and uncertainties
concerning: Solazyme’s commercialization plans for microalgal food ingredients
and the pricing, performance and health benefits of Solazyme’s microalgal food
ingredients. When used in this press release, the words "will", "expects",
"intends" and other similar expressions and any other statements that are not
historical facts are intended to identify those assertions as forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Any such statement may be influenced by a variety of factors, many of
which are beyond the control of Solazyme, that could cause actual outcomes and
results to be materially different from those projected, described, expressed
or implied in this press release due to a number of risks and uncertainties.
Potential risks and uncertainties include, among others: Solazyme's limited
operating history; its limited history in commercializing products;
implementation risk in deploying new technologies and products; and market
acceptance of its products. Accordingly, no assurances can be given that any
of the events anticipated by the forward-looking statements will transpire or
occur, or if any of them do so, what impact they will have on the results of
operations or financial condition of Solazyme. In addition, please refer to
the documents thatSolazyme, Inc.files with theSecurities and Exchange
Commission, including its Quarterly Reports on Form 10-Q, as updated from time
to time, for a discussion of these and other risks. You are cautioned not to
place undue reliance on forward-looking statements, which speak only as of the
date of this press release.Solazymeis not under any duty to update any of
the information in this press release.

Contact:

Solazyme, Inc.
Genet Garamendi, 650-780-4777
VP of Communications
press@solazyme.com
 
Press spacebar to pause and continue. Press esc to stop.